Tempus AI (NASDAQ:TEM) Shares Up 7.6% – Should You Buy?

Tempus AI, Inc. (NASDAQ:TEM)’s share price shot up 7.6% during trading on Friday . The stock traded as high as $56.48 and last traded at $56.47. 355,200 shares changed hands during trading, a decline of 70% from the average session volume of 1,195,705 shares. The stock had previously closed at $52.48.

Analyst Ratings Changes

Several research analysts have weighed in on TEM shares. Piper Sandler reissued a “neutral” rating and set a $70.00 price objective (up from $40.00) on shares of Tempus AI in a report on Tuesday, November 12th. JPMorgan Chase & Co. boosted their price objective on Tempus AI from $42.00 to $47.00 and gave the company an “overweight” rating in a research report on Wednesday, August 7th. Stifel Nicolaus cut shares of Tempus AI from a “buy” rating to a “hold” rating and increased their price objective for the company from $45.00 to $65.00 in a report on Monday, November 11th. Bank of America lowered Tempus AI from a “buy” rating to a “neutral” rating and upped their price objective for the company from $45.00 to $60.00 in a report on Wednesday, October 2nd. Finally, Needham & Company LLC restated a “buy” rating and set a $47.00 price objective on shares of Tempus AI in a research report on Wednesday, August 7th. Three investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $54.22.

Tempus AI Price Performance

The firm has a 50 day simple moving average of $51.80. The company has a current ratio of 2.69, a quick ratio of 2.55 and a debt-to-equity ratio of 8.17.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the company. First Horizon Advisors Inc. bought a new stake in shares of Tempus AI during the 3rd quarter valued at $30,000. Sandia Investment Management LP acquired a new position in Tempus AI during the second quarter worth $136,000. Vestor Capital LLC bought a new position in shares of Tempus AI in the 3rd quarter valued at about $153,000. Stifel Financial Corp acquired a new stake in shares of Tempus AI in the third quarter valued at about $218,000. Finally, IQ EQ FUND MANAGEMENT IRELAND Ltd bought a new stake in Tempus AI during the third quarter worth about $258,000.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.